QCM
ITCI

QRG Capital Management’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

QRG Capital Management’s Portfolio ITCI Stock Details ITCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-3,288
Closed -$434K – 1159
2025
Q1 		$434K Buy
+3,288
New +$410K ﹤0.01% 810

Other funds holding ITCI

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
KIM
Kestra Investment Management Austin, Texas $5.8B AUM 14.71% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

QRG Capital Management's ITCI Position: Q2 2025 in Review

QRG Capital Management sold out of Intra-Cellular Therapies Inc. (ITCI) in Q2 2025, closing a stake of 3,288 shares — an estimated $434K sold.

QRG Capital Management first reported a position in ITCI in Q1 2025 and held it in 1 quarter. The position peaked at $434K in Q1 2025. 4 funds tracked by Wall St. Rank hold ITCI as of Q2 2025.

  • QRG Capital Management reported no remaining Intra-Cellular Therapies Inc. position as of Q2 2025 after selling out during the quarter.
  • QRG Capital Management sold 3,288 Intra-Cellular Therapies Inc. shares in Q2 2025, an estimated $434K.
  • QRG Capital Management first reported a position in Intra-Cellular Therapies Inc. in Q1 2025 and held it in 1 quarter.
  • QRG Capital Management's Intra-Cellular Therapies Inc. position peaked at $434K in Q1 2025.
  • 4 funds tracked by Wall St. Rank held Intra-Cellular Therapies Inc. as of Q2 2025.

Based on QRG Capital Management's 13F filing for Q2 2025, filed 21 Jul 2025.